Childhood Large Cell Lymphoma

• CLINICAL_TRIALS trial_result · 2013-07-02
  Clinical Trial Update: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma [Phase 1]

  This phase 1 trial assessed safety and preliminary activity of the HDAC inhibitor vorinostat combined with bortezomib in pediatric patients …